Scott Wallask
Articles by Scott Wallask
Behind the Cat-and-Mouse Game of Lab Reimbursement
Financial relationships between clinical laboratories and commercial payers have evolved into a high-stakes, technological tug-of-war. For nearly a decade, the clinical laboratory industry has wrestled with the provisions of the Protecting Acce…
Expect RESULTS Act Vote by End of the Year
CEO SUMMARY: Evidence at the 2026 Executive War College suggests a coming push in clinical lab advocacy, focusing on the RESULTS Act to establish a permanent, database-driven reimbursement model. Simultaneously, federal regulators have floated the idea of heightened scruti…
Examining Roche’s Deal to Acquire PathAI
CEO SUMMARY: At first glance, Roche’s announcement that it had bought digital pathology and AI firm PathAI could be seen as a narrowing of options for clinical laboratories and pathology practices. However, insider Lisa-Jean Clifford says labs have long had access to dig…
Recent OIG Opinion Explores Lab-Urgent Care Arrangement
For decades, the US Department of Health and Human Services’ Office of Inspector General (OIG) has analyzed clinical laboratory business arrangements by asking how much compliance risk they pose. With the release of Advisory Opinion 26-02 on …
Artificial Intelligence Briefs
NYC Health CEO Suggests Replacing Radiologists with AI Anatomic pathologists may find concern in the words of Michael H. Katz, MD, the CEO at NYC Health + Hospitals, who indicated the system is prepared to substitute AI for radiologists in ce…
Digital Pathology’s Next Wave May Be in Precision Medicine
We’ve noted before that the adoption of digital pathology has not been as swift or strong as originally predicted. Many factors contribute to that concern. This topic came up in a recent interview The Dark Report conducted with Imoge…
Lab Fraudster Warned of ‘Bad Players’ in Old Interview
The audacity of some criminals can be startling. Using fraudulent reimbursement to buy expensive vehicles and mocking Medicare beneficiaries seem to be routine parts of the dishonesty playbook. Former NFL prospect Keith J. Gray, owner of two cl…
Revenue Concerns to Watch at Home and Abroad
This issue of The Dark Report explores…
Six Themes Define 2026 Executive War College
CEO SUMMARY: The 31st Annual Executive War College is just eight weeks away. From financial performance to digital pathology and AI, this year’s jam-packed conference will deliver practical solutions for today’s busy clinical laboratory executives. Despite stepping dow…
Office of Inspector General Briefs
Congress Wants Review of Test Fraud As part of a spending bill approved by Congress recently, there is a small provision that hints at future review of clinical laboratory tests by the US Department of Health and Human Services’ Office of Inspector General (OIG)….
CURRENT ISSUE
Volume XXXIII, No. 7 – May 26, 2026
Momentum is building on Capitol Hill to pass the RESULTS Act, which would stave off drastic 15% reimbursement cuts under PAMA. Advocates seek lobbying help from clinical labs and anatomic pathology practices. Also, The Dark Report examines Roche’s deal to acquire PathAI.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.